Ramifications of screening for breast cancer: 1 in 4 cancers detected by mammography are pseudocancers.
作者信息
Welch H Gilbert, Schwartz Lisa M, Woloshin Steven
出版信息
BMJ. 2006 Mar 25;332(7543):727. doi: 10.1136/bmj.332.7543.727.
Abstract
摘要
相似文献
1
Ramifications of screening for breast cancer: 1 in 4 cancers detected by mammography are pseudocancers.乳腺癌筛查的影响：通过乳房X光检查检测出的癌症中，四分之一是假癌。
BMJ. 2006 Mar 25;332(7543):727. doi: 10.1136/bmj.332.7543.727.
2
Ramifications of screening for breast cancer: consent for screening.乳腺癌筛查的影响：筛查同意书
BMJ. 2006 Mar 25;332(7543):728. doi: 10.1136/bmj.332.7543.728.
3
Ramifications of screening for breast cancer: definition of overdiagnosis is confusing in follow-up of Malmö trial.乳腺癌筛查的后果：在马尔默试验随访中，过度诊断的定义令人困惑。
BMJ. 2006 Mar 25;332(7543):727-8. doi: 10.1136/bmj.332.7543.727-b.
4
Ramifications of screening for breast cancer: more debate and better information still needed.乳腺癌筛查的影响：仍需更多辩论和更完善的信息。
BMJ. 2006 Mar 25;332(7543):728. doi: 10.1136/bmj.332.7543.728-a.
5
Ramifications of screening for breast cancer: overdiagnosis in the Malmö trial was considerably underestimated.乳腺癌筛查的后果：马尔默试验中的过度诊断被大大低估了。
BMJ. 2006 Mar 25;332(7543):727. doi: 10.1136/bmj.332.7543.727-a.
6
Over-diagnosis in breast cancer screening.乳腺癌筛查中的过度诊断。
BMJ. 2006 Mar 25;332(7543):691-2. doi: 10.1136/bmj.38768.401030.7C. Epub 2006 Mar 3.
7
Screening mammography in women 40 to 49 years of age.40至49岁女性的乳腺钼靶筛查。
Am Fam Physician. 2004 Nov 1;70(9):1750-2.
8
[The quality of mammography scrutinized. Ongoing control mass screenings for breast cancer is necessary].[乳腺钼靶检查质量的审视。持续进行乳腺癌控制群体筛查很有必要]
Lakartidningen. 1995 Aug 30;92(35):3106-9.
9
[Cancer screening: medico-legal aspects].[癌症筛查：医学法律方面]
Ann Ig. 2003 Jan-Feb;15(1):3-10.
10
Significant reduction in advanced breast cancer. Results of the first seven years of mammography screening in Kopparberg, Sweden.晚期乳腺癌显著减少。瑞典耶夫勒市乳腺钼靶筛查头七年的结果。
Diagn Imaging Clin Med. 1985;54(3-4):158-64.
引用本文的文献
1
Patient Preferences for Outcomes Following DCIS Management Strategies: A Discrete Choice Experiment.患者对 DCIS 管理策略相关结局的偏好：一项离散选择实验。
JCO Oncol Pract. 2021 Nov;17(11):e1639-e1648. doi: 10.1200/OP.20.00614. Epub 2021 Mar 12.
2
Overdiagnosis in urologic cancer : For World Journal of Urology Symposium on active surveillance in prostate and renal cancer.泌尿系统癌症中的过度诊断：世界泌尿外科学会前列腺癌和肾癌主动监测专题研讨会论文集
World J Urol. 2022 Jan;40(1):1-8. doi: 10.1007/s00345-020-03523-2. Epub 2021 Jan 25.
3
Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control Study.小的无症状胰腺神经内分泌肿瘤的观察与切除：一项配对病例对照研究
Ann Surg Oncol. 2016 Apr;23(4):1361-70. doi: 10.1245/s10434-015-4986-1. Epub 2015 Nov 23.
4
Clinicopathologic characteristics and molecular subtypes of microinvasive carcinoma of the breast.乳腺微浸润癌的临床病理特征及分子亚型
Tumour Biol. 2015 Apr;36(4):2241-8. doi: 10.1007/s13277-014-2652-z. Epub 2015 Mar 24.
5
Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods.量化和监测癌症筛查中的过度诊断：方法的系统评价
BMJ. 2015 Jan 7;350:g7773. doi: 10.1136/bmj.g7773.
6
Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis.癌症筛查中过长的领先时间导致了对过度诊断的严重低估。
Br J Cancer. 2013 Oct 1;109(7):2014-9. doi: 10.1038/bjc.2013.427. Epub 2013 Aug 20.
7
The challenge of conducting comparative effectiveness research in cancer: the impact of a fragmented U.S. health-care system.开展癌症比较疗效研究面临的挑战：美国碎片化医疗体系的影响。
J Natl Cancer Inst Monogr. 2013;2013(46):99-105. doi: 10.1093/jncimonographs/lgt008.
8
The benefits and harms of breast cancer screening: an independent review.乳腺癌筛查的益处与危害：一项独立综述。
Br J Cancer. 2013 Jun 11;108(11):2205-40. doi: 10.1038/bjc.2013.177. Epub 2013 Jun 6.
9
How do I screen patients for breast cancer?我该如何对乳腺癌患者进行筛查？
Curr Treat Options Oncol. 2013 Mar;14(1):88-96. doi: 10.1007/s11864-012-0218-0.
10
Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women.在一项针对 28104 名新加坡女性的前瞻性全国性研究中验证 Gail 模型预测个体乳腺癌风险的能力。
Breast Cancer Res. 2012 Jan 30;14(1):R19. doi: 10.1186/bcr3104.
本文引用的文献
1
Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study.马尔默乳腺钼靶筛查试验结束15年后乳腺癌的过度诊断率：随访研究
BMJ. 2006 Mar 25;332(7543):689-92. doi: 10.1136/bmj.38764.572569.7C. Epub 2006 Mar 3.
2
Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.乳腺钼靶筛查与乳腺癌死亡率：马尔默乳腺钼靶筛查试验
BMJ. 1988 Oct 15;297(6654):943-8. doi: 10.1136/bmj.297.6654.943.
Zotero 插件